2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Paper Details

Abstracts, authors, affiliations, and disclosures.

Saturday, December 12, 2026
05:30 p.m. - 07:30 p.m.
MCCNO - Hall F
Technology and Procedures, Assays, Imaging, Omics Technologies, Bioinformatics, Cell Expansion, Computational Biology, Biological Processes, Genomics, Hematopoiesis, Immune Mechanism, Metabolism, Molecular Biology, Diseases, Myeloid Malignancies, Chronic Myeloid Malignancies, Research, Fundamental Science, Translational Research, Study Population, Human, Animal Model
PAPER

1363 Molecular mechanisms of asymmetric lysosome segregation and cell fate decisions in dividing hematopoietic stem cells

Jessica Nunes, PhD, Soumen Bera, PhD2, Dirk Loeffler, PhD3
1 St. Jude Children's Research Hospital, Memphis, Tennessee, United States
2 St. Jude Children's Research Hospital, Memphis, Tennessee, United States
3 St Jude Children's Research Hospital, Memphis, Tennessee, United States, St. Jude Children's Research Hospital, Memphis, Tennessee, United States, The University of Tennessee, Memphis, Tennessee, United States

Background: Hematopoietic stem cells (HSCs) can differentiate into all blood cells and self-renew to maintain a lifelong stem cell pool. To accomplish this, HSCs can divide symmetrically to give rise to daughter cells with the same fate or asymmetrically to give rise to daughter cells with different fates. During asymmetric cell divisions (ACD), cell fate determinants segregate unequally into the daughter cell to instruct cell fate divergence. While studies of invertebrate model systems have shown that ACD mechanisms can vary widely across organisms and tissues, technical limitations have made detailed studies of division in primary hematopoietic stem and progenitor cells difficult. To overcome these challenges, we recently developed long-term quantitative live cell imaging. This approach allows us to link mitotic marker segregation of rare primary HSCs to paired-daughter cell fates many days and cell generations later. Using this approach, we discovered that lysosomes and vesicles of the endo-lysosomal degradative machinery can segregate asymmetrically, predicting later metabolic activity and differentiation of HSC daughters. However, although our work showed that HSCs can use ACD to regulate daughter cell fates, the molecular mechanisms and pathways regulating ACD of HSCs remained unclear.

Methods: To identify how HSCs regulate asymmetric lysosome segregation and how lysosomes might instruct HSC daughter fates, we combined pharmacological and genetic perturbations with improved quantitative live-cell imaging of highly purified mouse HSCs to track and quantify the behavior and marker expression of HSCs and their offspring for several cell generations ex vivo. Imaging analysis, single-cell tracking, and quantification of single-cell dynamics in dividing HSCs and paired daughter fates allowed us to interrogate how changes in lysosome segregation affect subsequent cell fates. To obtain detailed structural information on the position and organization of lysosomes in dividing HSCs, we complemented this approach with 3-dimensional super-resolution imaging and novel high-temporal resolution imaging to simultaneously capture, track, and quantify lysosome motility and molecular marker dynamics in dividing ultra-rare primary HSCs. 

Results: Using these tools and over a dozen molecular perturbations, we identify the small RhoGTPase CDC42 as a key regulator of mitotic lysosome segregation in HSCs and discover that the actin cytoskeleton is a key regulator of symmetric vs. asymmetric lysosome motility in dividing HSCs. In addition to changing lysosome segregation, we find that inhibition of CDC42 and several of its downstream regulators alters paired daughter cell fates, linking changes in lysosome segregation and the actin cytoskeleton to functional changes at the single-cell level. Using novel bio-image analysis tools and pipelines, we were further able to trace and quantify lysosome motility in dividing HSCs, allowing us to develop a step-by-step model describing how subcellular lysosome position and localized subcellular actin dynamics lead to symmetric and asymmetric HSC divisions.

Conclusions: Together, our work uncovers the CDC42-Actin axis as a key molecular pathway regulating symmetric vs. asymmetric segregation of lysosomes in primary HSCs and discovers novel, surprising insights into how HSCs orchestrate organelle motility and subcellular molecular dynamics to instruct HSC daughter cell fate diversification during division.  

Jessica Nunes, PhD: No relevant conflicts of interest to declare.